|Articles|July 15, 2019
CTI Signs Memorandum with Samsung Medical Center
Advertisement
CTI Clinical Trial and Consulting Services has signed a Memorandum of Understanding with Samsung Medical Center to affirm their commitments to identifying and developing opportunities for collaboration and cooperation in advancing clinical research in fields such as rare and orphan disease.
To learn more, click
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Approves Subcutaneous Lunsumio VELO Based on GO29781 Trial Results in Relapsed or Refractory Follicular Lymphoma
2
Applying AI to Automate Workflows Without Disrupting Sites
3
ACT Brief: Building a Digital Thread in Life Sciences, CRO Sourcing Decisions and Site Burden, and Lilly’s Oral GLP-1 Phase III Results
4
Life Sciences Can’t Afford Fragmented Data and Disconnected Teams
5